<?xml version="1.0" encoding="UTF-8"?>
<p id="par0130">Therefore, both nigellimine and thymoquinone from 
 <italic>N. sativa</italic> might be considered as potential medicinally bioactive components to treat COVID-19 patients.
</p>
